Thursday, 6 December 2018

Mallinckrodt plans to spin off specialty generics business

Drugmaker Mallinckrodt Plc said on Thursday it planned to spin off its specialty generics business to shareholders by the second half of 2019.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)